tiprankstipranks
Anbio Biotechnology Class A (NNNN)
NASDAQ:NNNN
US Market
NNNN
Anbio Biotechnology Class A
RESEARCH TOOLSreports
Want to see NNNN full AI Analyst Report?

Anbio Biotechnology Class A (NNNN) Income Statement

60 Followers

Anbio Biotechnology Class A Income Statement

Last quarter (Q4 2024), Anbio Biotechnology Class A's total revenue was $2.53M, a decrease of -60.01% from previous quarter. In Q4, Anbio Biotechnology Class A's net income was $-1.32M. See Anbio Biotechnology Class A’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 9.76M$ 8.19M$ 6.71M$ 23.54M$ 4.43M
Gross Profit
$ 8.51M$ 5.89M$ 3.36M$ 12.56M$ 2.54M
Operating Expenses
$ 2.00M$ 3.89M$ 1.40M$ 2.37M$ 86.09K
Depreciation and Amortization
$ 0.00$ 0.00$ 13.04K$ 6.25K$ 0.00
EBITDA
$ 6.51M$ 2.57M$ 2.27M$ 10.03M$ 2.54M
Operating Income
$ 6.51M$ 2.00M$ 1.96M$ 10.20M$ 2.46M
Other Income/Expenses
$ 717.46K$ 377.48K$ 292.78K$ -184.41K$ 79.94K
Pretax Income
$ 7.23M$ 2.37M$ 2.25M$ 10.01M$ 2.54M
Net Income
$ 7.23M$ 2.37M$ 2.25M$ 10.01M$ 2.54M
Per Share Metrics
Basic EPS
$ 0.16$ 0.06$ 0.02$ 0.07$ 0.03
Diluted EPS
$ 0.16$ 0.06$ 0.01$ 0.07$ 0.03
Weighted Average Shares Outstanding
 43.89M 42.29M 143.89M 143.89M 100.00M
Weighted Average Shares Outstanding (Diluted)
 43.89M 42.29M 187.78M 143.89M 100.00M
Currency in USD

Anbio Biotechnology Class A Earnings and Revenue History